Status:

COMPLETED

Enalapril in Collagen Type 4 Nephropathy

Lead Sponsor:

University of Sao Paulo

Conditions:

Collagen Type-4 Nephropathies

Eligibility:

All Genders

Up to 18 years

Brief Summary

Background: Collagen IV-related nephropathies can lead to End Stage Renal Disease. Experimental studies have shown renin angiotensin aldosterone system blockade can reduce proteinuria and preserve ren...

Detailed Description

Introduction Collagen IV-related nephropathies, caused by mutations in the three genes encoding collagen type IV of the basal membrane, represent a spectrum of phenotypes from Alport syndrome (AS) to ...

Eligibility Criteria

Inclusion

  • age under 18 years old
  • non-adherent to the exams and evaluations

Exclusion

  • creatinine clearance \< 60 ml/minute/1.73m2BS

Key Trial Info

Start Date :

January 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2011

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT01465126

Start Date

January 1 2011

End Date

October 1 2011

Last Update

November 4 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.